Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data
Tweet Send to a Friend
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) announced it will host a conference call on June 13 at 9:00 a.m. ET to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


